CSTL EPS Estimates
Castle Biosciences, Inc.
$33.11
+$0.23(+0.70%)
57
Overall
60
Value
54
Tech
57
Quality
Market Cap
$1.01B
Volume
243.17K
52W Range
$17.72 - $44.28
Target Price
$45.11
CSTL EPS estimates: the consensus estimate for Castle Biosciences, Inc.'s current fiscal year is -$1.29 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CSTL EPS Estimates
- EPS estimate, current quarter
- $-0.38
- EPS estimate, next quarter
- $-0.36
- EPS estimate, current year
- $-1.29
- EPS estimate, next year
- $-0.93
- EPS growth, 3-year
- +31.48%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.83 |
| 2024 | $0.66 |
| 2023 | $-2.14 |
| 2022 | $-2.58 |
| 2021 | $-1.24 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CSTL | $33.11 | +0.7% | 243.17K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Castle Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW